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Abstract
The objective was to compare pharmacological strategies aiming to inhibit prostaglandin F2 alpha (PGF2) synthesis (flunixin
eglumine; FM), stimulate growth of the conceptus (recombinant bovine somatotropin; bST) and progesterone (P4) synthesis
human chorionic gonadotropin; hCG), as well as their combinations, regarding their ability to improve pregnancy rates in beef
attle. Lactating Nelore cows (N  975), 35 to 70 days postpartum, were synchronized and inseminated by timed artificial
nsemination (TAI) on Day 0. On Day 7, cattle were allocated into eight groups and received one of the following treatments:
aline (S) on Days 7 and 16 (Group Control); S on Day 7 and FM on Day 16 (Group FM); bST on Day 7 and S on Day 16 (Group
ST); bST on Day 7 and FM on Day 16 (Group bST  FM); hCG on Day 7 and S on Day 16 (Group hCG); hCG on Day 7 and
M on Day 16 (Group hCG  FM); bST and hCG on Day 7 and S on Day 16 (Group bST  hCG), or bST and hCG on Day
7 and FM on Day 16 (Group bST  hCG  FM). The aforementioned treatments were administered at the following doses: 2.2
mg/kg FM (Banamine®; Intervet Schering-Plough, Cotia, SP, Brazil), 500 mg bST (Boostin®; Intervet Schering-Plough), and
2500 IU hCG (Chorulon®; Intervet Schering-Plough). Pregnancy diagnosis was performed 40 days after TAI by transrectal
ultrasonography. Pregnancy rates were not significantly different among treatments. However, there was a main effect of hCG
treatment to increase pregnancy rates (63.0 vs. 55.4%; P  0.001). Concentrations of P4 did not differ significantly among groups
n Day 7 or on Day 16. However, consistent with the higher pregnancy rates, hCG increased P4 concentrations on Day 16 (10.6
vs. 9.6 ng/mL, respectively; P  0.05). We concluded that hCG treatment 7 days after TAI improved pregnancy rates of lactating
Nelore cows, possibly via a mechanism leading to induction of higher P4 concentLrations, or by reducing the luteolytic stimulu
uring maternal recognition of pregnancy.
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In cattle, fertilization rates can reach 100% [1–3]
hereas the rates of live births after a single insemina-
ion are only 53% [4]. There are reports indicating that
he majority of the reproductive losses during gestation
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ing maternal recognition of pregnancy, at approxi-
mately Day 16 in cattle, the conceptus secretes mole-
cules that signal to the endometrium to block
prostaglandin F2 alpha (PGF2) synthesis, preventing
uteolysis [6,7]. Therefore, pharmacological strategies
iming to inhibit the synthesis of PGF2 are used to
educe embryonic mortality.
According to the cellular model for PGF2 biosyn-
hesis proposed by Burns et al. [8], free arachidonic
cid (AA) is converted to prostaglandin H2 by the
cycloxygenase 2 enzyme (COX-2). Nonsteroidal anti-
inflammatory drugs, such as flunixin meglumine (FM),
inhibit PGF2 synthesis by inhibiting the COX-2 en-
zyme, and have positive effects on pregnancy rates
when administered between Days 14 and 17 post-AI
[9,10]. Other studies, however, reported no effect of
FM on pregnancy rates [11].
There is a positive correlation between the size of
the conceptus and the amount of interferon (IFN)-, a
otent PGF2 synthesis inhibitor, secreted during ma-
ternal recognition of pregnancy [12]. Consistently,
smaller conceptuses secreted less IFN- and were as-
sociated with higher rates of pregnancy loss. Recombi-
nant bovine somatotropin (bST) has been associated
with faster conceptus growth and increased preg-
nancy rates [13–16]. However other studies have
observed no effect of bST on the aforementioned end
points [17–19].
Human chorionic gonadotropin (hCG) has LH-like
activity, and when given to cattle between 4 and 7 days
post-estrus, induces formation of an accessory CL,
thereby increasing progesterone (P4) concentrations
20]. Numerous studies reported the positive effect of
igher systemic P4 concentrations on early embryonic
evelopment in cattle [21–24]. Cows with higher en-
ogenous P4 had an increased rate of embryonic growth
and consequently greater IFN- production [25]. There
are reports of higher pregnancy rates in cattle treated
with hCG [26,27], whereas other studies detected an
increase in systemic P4 concentrations, but no effect on
pregnancy rates [28,29].
There are limited data regarding the benefits of the
aforementioned strategies in beef cattle, particularly in
Nelore (Bos taurus indicus). Moreover, no assessment
of the effects of FM, bST, and hCG, and their combi-
nations, on pregnancy rates has been conducted in a
single study with contemporaneous treatments and a
large sample size. Therefore, the overall aim of this
study was to test the effects of FM, bST, and hCG on
plasma P4 concentrations on Days 7 and 16 after timed trtificial insemination (TAI) and pregnancy rates of
elore cows on Day 40 post-TAI. Our hypothesis was
hat treatment with FM, bST, and/or hCG leads to
igher pregnancy rates, potentially by directly (hCG) or
ndirectly (FM and bST) stimulating and/or maintain-
ng P4 production.
. Materials and methods
.1. Location, animal facilities and animal
anagement
The experiment was performed on two farms. One
arm was located in São Félix do Araguaia, in the state
f Mato Grosso (latitude 11°37’02’’ S, longitude
0°40’10’’ W, altitude 195 m), whereas the other farm
as located in Andradina, in the state of São Paulo
latitude 20°53’ S, longitude 51°22’ W, altitude 387 m).
ine hundred seventy-five Nelore cattle (Bos taurus
ndicus) were used (244 heifers and 731 cows). These
attle were between 35 and 70 days postpartum on the
ay they received the intravaginal P4 device, with an
verage body condition score (BCS) of 2.8  0.2
range, 1 to 5). Females were kept on pasture composed
f Brachiaria brizantha cv. Marandu, Panicum maxi-
um cv. Tanzânia and Panicum maximum Jacq cv.
olonião with mineral supplementation and water ad
ibitum. Animal handling protocols were approved by
he Ethics and Animal Experimentation Committee
rom UNESP – Dracena, São Paulo, Brazil (Process #
02/2008).
.2. Timed artificial insemination (TAI)
Estrus synchronization was started by inserting an
ntravaginal device containing 1 g of P4 (DIB®; Intervet
Schering-Plough, Cotia, SP, Brazil), along with an im
injection of 2 mg of estradiol benzoate (Gonadiol®;
Intervet Schering-Plough). The day the P4 device was
inserted was considered Day –10. On Day –2, devices
were removed and animals received an im injection of
112.5 g of D-cloprostenol (Preloban®; Intervet Scher-
ing-Plough), an im injection of 300 IU of eCG (Folli-
gon®; Intervet Schering-Plough), and 1 mg of estradiol
cypionate (ECP®; Pfizer, Chácara Santo Antônio, SP,
razil). Forty-eight hours after the last injection, cattle
ere bred by TAI (Day 0). One of the farms used
emen from two Simmental and two Nelore bulls,
hereas the other farm used semen from 15 Nelore
ulls. Bulls were distributed homogeneously among
xperimental groups and each farm used their own
echnicians to perform TAI.
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After TAI, females (N  975) were allocated into
ight groups. Postpartum status, BCS and semen source
ere homogeneously represented among experimental
roups. Starting on Day 7, each group received one of
he following treatments: saline (S) on Day 7 and S on
ay 16 (Control Group; N  124); S on Day 7 and FM
n Day 16 (Group FM; N  122); bST on Day 7 and
on Day 16 (Group bST; N 119); bST on Day 7 and
M on Day 16 (Group bST  FM; N  121); hCG on
ay 7 and S on Day 16 (Group hCG; N  124); hCG
n Day 7 and FM on Day 16 (Group hCG  FM; N 
24); bST and hCG on Day 7 and S on Day 16 (Group
ST  hCG; N  120), or bST and hCG on Day 7 and
M on Day 16 (Group bST  hCG  FM; N  121).
Saline (2.5 mL), hCG (Chorulon®; Intervet Schering-
lough; 2500 IU), and FM (Banamine®; Intervet Scher-
ing-Plough; 2.2 mg/kg) were given as im injections.
Recombinant bovine somatotropin (Boostin®; Intervet
chering-Plough; 500 mg/animal) was given as a sc
njection. On Days 7 and 16 after TAI, approximately 8
L of blood were collected from the coccygeal vessels
nto vials containing 175 L of 30% sodium citrate.
Blood was centrifuged at 1000 X g for 30 min at 4 °C.
After centrifugation, plasma was stored at –20 °C. Due
to the large number of cattle used in the study and high
costs associated with hormone assays, 44% of animals
in each group were selected randomly and plasma P4
concentrations were measured by RIA (Count-a-
Count®, DPC, Diagnostic Products Corporation; Los
Angeles, CA, USA) on blood samples collected from
these animals on both Days 7 and 16. Progesterone
determinations were obtained in three assays. To deter-
mine intra- and interassay variability, high P4 reference
samples (HPR) and low P4 reference samples (LPR)
were used. The HPR reference samples had 1.6%,
1.6%, and 1.4% intra-assay CV, for assays 1, 2, and 3,
respectively, whereas LPR reference samples had intra-
assay CV of 0.1%, 0.05%, and 0.03%, for assays 1, 2,
and 3, respectively. Interassay CV was 5.3% for HPR
and 3.0% for LPR. Assay sensitivity for assays 1, 2, and
3 were 0.005, 0.005, and 0.008 ng/mL, respectively.
Pregnancy was diagnosed by transrectal ultrasonogra-
phy 40 days after TAI (Aloka Ultrasound Diagnostic
Equipment, Model SSD-500, Tokyo, Japan with a 5
MHz, linear-array transducer).
2.4. Statistical analysis
The general assumption for binary variables such as
pregnancy rate on Day 40 after TAI is that they have a
Bernoulli distribution, which is a particular case ofgeneral linear models. Supposing that Yi, i 1, 2. . ., in
which i represents one of the measured variables, Yi 
Bernouille (¶i), and ¶ is the probability of success
(pregnancy probability), the probability function of Yi,
is calculated by:
PYi yi ¶yii1 ¶i1 yi, yi 0, 1
Pregnancy rate at Day 40 after TAI was analyzed by
logistic regression using the GLIMMIX procedure from
SAS (Version 9.1 of the SAS System for Windows,
SAS Institute Inc., Cary, NC, USA). The independent
variables initially included on the statistical model were
the effects of farm, BCS, FM, bST, hCG, and their
interactions. To obtain the final statistical model, the
explanatory variables were sequentially removed based
on the statistical criterion of Wald, using a P value cut
off of P  0.2. The explanatory variables included in
the final model were farm and hCG treatment.
Progesterone concentrations on Days 7 and 16
matched the criteria for normally distributed residuals
(Shapiro-Wilk test; P  0.01) and homogeneity of
variances (F test; P  0.01), according to the function
Guided Data Analysis from SAS, and were analyzed by
ANOVA using the PROC GLM procedure from SAS.
Data were analyzed using two independent models. In
the first model, data were analyzed as a completely
randomized design and the independent variable was
treatment; in the second model data were analyzed as a
2  2  2 factorial design and the independent vari-
ables were hCG, bST, FM, and all second and third
degree interactions. Continuous variables were ex-
pressed as mean  SEM. A significance level of 5%
as used for all data analyses.
. Results
.1. Pregnancy rates on Day 40 post-TAI
Pregnancy rates were not different among groups (P
.05; Table 1). Cattle receiving hCG had a 7.6% higher
regnancy rate (P  0.001). In contrast, none of the
main effects of bST and FM, nor any interactions, were
significant.
3.2. Effects of treatments on P4 plasma
concentrations measured on Days 7 and 16
There was no significant difference among groups
for plasma P4 concentrations on Days 7 or 16 (Table 2).
However, there was an 11.1% average increase in P4
concentrations on Day 16 (1.07 ng/mL) for cows re-
ceiving hCG compared with cows not receiving (hCG
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Days 7 and 16 were not affected by bST, FM, or
interactions among hCG, bST, and FM (P  0.05).
4. Discussion
In an effort to determine whether FM, bST, or hCG
affected pregnancy rates by preventing luteolysis or
improving P4 concentrations, our work has, for the first
ime, assessed the effects of these compounds, and their
ombinations, in a single study. Furthermore, the pres-
nt study used a substantial number of experimental
nits (approximately 120 per experimental group), in
he same reproductive stage (lactating cows/heifers)
rom the same beef breed (Nelore). Our main findings
ere that: (1) hCG treatment (2500 IU/animal) on Day
post-TAI induced greater pregnancy rates and in-
reased plasma P4 concentrations on Day 16 after TAI;
(2) a single dose of bST (500 mg/animal) on Day 7 did
not significantly affect pregnancy rates; and (3) a single
dose of FM (2.2 mg/kg) on Day 16 did not significantly
affect pregnancy rates.
Although pregnancy rates were not significantly dif-
ferent among all eight groups, there was a main effect
of hCG to increase pregnancy rates (7.6%; P  0.01).
Table 1
Pregnancy rates on Day 40 (timed AI was done on Day 0) in
Nelore cows that received saline (Control), flunixin meglumine on
Day 16 (FM), bovine somatotropin (bST) on Day 7 (bST), bST on
Day 7 and FM on Day 16 (bST  FM), human chorionic
gonadotropin (hCG) on Day 7 (hCG), hCG on Day 7 and FM on
Day 16 (hCG  FM), bST and hCG on Day 7 (bST  hCG), or
bST and hCG on Day 7 and FM on Day 16 (bST  hCG  FM),
and the main effects of hCG, bST, or FM treatments.
Treatment N Pregnancy rates % (N)
ontrol 124 57.3 (71)
M 122 47.5 (58)
ST 119 60.5 (72)
ST  FM 121 56.2 (68)
hCG 124 59.7 (74)
hCG  FM 124 64.5 (80)
bST  hCG 120 63.3 (76)
bST  hCG  FM 121 64.5 (78)
P  0.4995
hCG untreated 486 55.4 (269)
hCG treated 489 63.0 (308)
P  0.001
bST untreated 494 57.3 (283)
bST treated 481 61.1 (294)
P  0.210
FM untreated 487 60.2 (293)
FM treated 488 58.2 (284)
P  0.460Other studies in cattle had already reported positiveeffects of hCG treatment on pregnancy rates when it
was given between Days 4 and 7 post-AI [26,27,30];
this was attributed to the ability of hCG to increase P4
plasma concentrations [26,27]. It is well known that
treatment with GnRH, LH, or hCG given between 4 and
7 days postestrus stimulates ovulation of the dominant
follicle from the first wave of follicular growth, leading
to the formation of an accessory CL [26,31]. Another
activity associated with hCG is its ability to stimulate
the original CL by acting on small and large luteal cells
[32] to result in greater P4 output. It is well known that
CG has a longer half-life than GnRH or LH and a
ower rate of dissociation from the ligand-receptor
omplex. These particular hCG characteristics pro-
oted a more prolonged stimulus of the LH receptors
n target cells [33], leading to an increase in CL weight
34]. Therefore, the positive effects of hCG on P4
concentrations were likely due to its effects on the
original CL, as well as on the formation of an accessory
CL. In the present experiment, and in agreement with
our initial hypothesis, hCG treatment 7 days after TAI
increased P4 concentrations and this was associated
with a greater pregnancy rate. We propose that greater
Table 2
Plasma progesterone concentrations on Days 7 and 16 (timed AI
was done on Day 0) in Nelore cows that received saline (Control),
flunixin meglumine (FM) on Day 16 (FM), bovine somatotropin
(bST) on Day 7 (bST), bST on Day 7  FM on Day 16 (bST 
FM), human chorionic gonadotropin (hCG) on Day 7 (hCG), hCG
on Day 7 and FM on Day 16 (hCG  FM), bST and hCG on Day
7 (bST  hCG), or bST and hCG on Day 7 and FM on Day
16 (bST  hCG  FM), and the main effect of hCG, bST, or FM
treatments.
Treatment P4 Concentration
(ng/mL) on Day
7 (mean  SEM)
P4 Concentration
(ng/mL) on Day
16 (mean  SEM)
Control 4.73  0.33 8.66  0.72
FM 5.15  0.32 9.11  0.65
bST 5.48  0.38 11.39  0.85
bST  FM 5.19  0.39 9.02  0.74
hCG 5.64  0.45 10.80  0.78
hCG  FM 5.07  0.43 10.46  0.88
bST  hCG 5.18  0.33 10.70  0.73
bST  hCG  FM 5.18  0.37 10.53  0.77
P  0.8425 P  0.1110
hCG untreated 5.14  0.18 9.56  0.38
hCG treated 5.27  0.20 10.63  0.39
P  0.6326 P  0.0490
bST untreated 5.15  0.19 9.76  0.38
bST treated 5.26  0.19 10.41  0.39
P  0.6863 P  0.2312
FM untreated 5.26  0.19 10.41  0.39
FM treated 5.15  0.19 9.78  0.38P  0.6898 P  0.2624
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cretions that make the uterine microenvironment more
suitable for conceptus development. Larger concep-
tuses have higher capacity to produce and secrete IFN-
and block PGF2 synthesis by the endometrium, which
will ultimately lead to a greater probability of main-
taining pregnancy.
However, it is important to consider potential mech-
anisms induced by hCG that are independent of P4. The
pattern of changes in pregnancy rates in response to
increasing concentrations of P4 has not been deter-
ined for postpartum Nelore females, such as those
sed in this study. It is not known whether there is a
hreshold of response to increasing P4. For lactating
dairy cows, with much lower P4 concentrations, there
as a clear, linear increase in pregnancy rates as
lasma P4 increased [35]. However, such a positive
elationship may be different for beef cows and the 1
g/mL increase in P4 induced by hCG may not indeed
improve pregnancy rates, especially because cows that
did not receive hCG had relatively high (9.56 ng/mL)
P4 concentrations. Giving hCG on Day 7 likely caused
vulation of the first wave-dominant follicle and repro-
rammed follicular development, hastening emergence
f the second wave. Because timing of luteolysis is
egulated by follicular estradiol [36], such reprogram-
ing may delay luteolysis. Indeed, based on previous
ata from our group [20], we inferred that hCG delayed
uteolysis an average of 1.6 days compared with non-
njected cows. Perhaps a delay in luteolysis increased
he odds of embryo survival, because it would give the
onceptus more time to elongate and secrete enough
FN- to trigger an antiluteolytic response in the dam.
It was shown previously that cows given bST during
estrus had greater pregnancy rates than controls [13].
Receptors for bST and insulin-like growth factor
(IGF)-1 are expressed in the bovine endometrium, spe-
cifically in the endometrial glands [37]. It is possible
that an increase in IGF-1 concentrations in response to
bST treatment increases the secretory activity of the
endometrial glands, leading to a uterine environment
more favorable to the development of the conceptus,
facilitating maintenance of pregnancy [13]. Indeed, in
dairy cattle, bST treatment increased IFN- concentra-
ions in uterine secretions [38].
Administration of bST on Day 7 failed to increase
regnancy rate in the current study. Although the dose
f bST used was identical to that used in studies that
howed a positive effect of bST on pregnancy rate
13,39,40], the absence of a significant effect in the
resent study may have been due to the day of treat-ent. Indeed, administration of bST at estrus increased
lood concentrations of bST and IGF-1 concentrations
or 14 days [41] and pregnancy rates [13]. It may be
peculated that bST and IGF-1 affect events that take
lace in the preovulatory follicle, oviduct, endome-
rium and/or the early conceptus within the interval
etween estrus and Day 7 postestrus to result on an
nvironment more conducive to the establishment of
regnancy. For example, treatment with bST increased
GF-1 concentrations, which in turn is important for
bsorption of lipoproteins and steroidogenesis of gran-
losa cells, thus stimulating P4 synthesis on the newly-
ormed CL [42]. Conversely, in the beef cows of the
resent experiment, which have greater blood IGF-1
oncentrations than dairy cows during lactation, exog-
nous bST may not be sufficient to cause the expected
ffects, because blood concentrations of bST and IGF-1
re already elevated [43].
In the present study, FM affected neither pregnancy
ates nor P4 concentrations. The recommended treat-
ment with FM consists of two 1.1 mg/kg of body
weight injections, given 12 h apart [10]. In the present
study, due to the difficulties imposed by behavioral
issues of Bos taurus indicus cows and to accommodate
animal management, we chose to minimize handling by
giving a single injection of 2.2 mg/kg. Flunixin meglu-
mine is a potent nonsteroidal anti-inflammatory com-
pound that inhibits COX-2 conversion of AA into pros-
taglandin H2 [44]. Intramuscular injection of FM
decreases PGFM plasma concentrations in nonlactating
cows within 12 h [45]. The mechanism of action de-
scribed above and reports indicating increased preg-
nancy rates after AI [9] or embryo transfer (ET) [46,47]
in response to FM treatment led to the hypothesis that
the use of FM increases pregnancy rates. The present
results were not consistent with a previous report of
higher pregnancy rates in cows given FM 14 days after
AI [9]. However, that experiment involved exposing
animals to stress, which in combination with FM treat-
ment might have accentuated differences between
treated and untreated animals, because stressful han-
dling of animals post-AI induced embryonic mortality
[48]. Other studies reported an increase in the interval
between ovulation and luteolysis, suggesting that FM
could delay the latter process [44,49]. Delaying lute-
olysis might allow more time for the embryo to develop
and secrete enough IFN- to induce maternal recogni-
tion of pregnancy [49]. Although the conceptus is able
to secrete considerable amounts of IFN- by Day 14 of
pregnancy, it was suggested that pulses of PGF2
reached their maximum amplitude at approximately
ce
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756 R.C. Rossetti et al. / Theriogenology 76 (2011) 751–758Days 15 and 17 [6,50]. Considering that the half-life of
FM is 24 h [45], the timing of treatment in the current
study may have not been optimal, as the luteolytic
mechanisms could have started in some cows before
Day 16. In order to better define conditions that are
more favorable to the improvement of pregnancy rates
upon FM treatment, more studies involving timing of
administration, dose, and length of treatment are nec-
essary.
Numerous studies have reported that higher P4 con-
entrations during early pregnancy modulate the uterine
nvironment, generating more favorable conditions for
he embryonic development, higher IFN- production,
and pregnancy rates in cattle [21–24,51]. However,
timing and magnitude of the P4 increase postestrus is
ritical. For example, Geisert et al. [25] observed that
cows treated with P4 had embryos with increased em-
bryonic growth rates and higher production of IFN-.
arter et al. [51] also reported that higher P4 concen-
rations during the immediate post-AI period were as-
ociated with increased embryonic growth rate, IFN-
production, and higher pregnancy rates. Consistently,
Wathes et al. [52] suggested that a delay in the rise of
milk P4 concentrations was associated with low preg-
ancy rates. Therefore, we inferred that higher P4 con-
centrations within the first week of pregnancy were
associated with higher pregnancy rates. Thus, treat-
ments designed to stimulate a quick elevation of P4
concentrations should be beneficial to conceptus devel-
opment. In the present study, strategies were designed
to stimulate P4 production after Day 7, which may at
least partially explain the limited beneficial effects ob-
served. Strategies that aim to increase rate of P4 in-
crease between ovulation and Day 7 are promising and
warrant further investigation.
As a final point of discussion, it is important to
speculate on the factors limiting pregnancy rates in
postpartum Bos taurus indicus cattle raised in the trop-
cs under grazing conditions. Understanding such lim-
tations will lead to the development of new strategies
hat will lead to higher reproductive efficiency. In the
resent study, strategies aimed essentially at favoring
onceptus growth and inhibiting luteolysis, but success
as limited to administration of hCG. This overall
esult may be related to the fact that all cattle received
CG during the synchronization protocol. It is notewor-
hy that eCG increases growth of the preovulatory fol-
icle and ovulation rate, P4 production by the resulting
L, and pregnancy rates in beef cattle [53]. Thus,
regnancy rates for cattle in the present study were not
ikely limited by insufficient P4. In addition to modu-ating endometrial glandular secretions that regulate
onceptus growth [54], dos Santos and coworkers [55]
reported that elevated P4 concentrations stimulated syn-
thesis of PGF2. Thus, strategies aiming to retard or
block luteolysis may be useful to increase pregnancy
rates in situations where P4 is not limiting. Such strat-
egies may include reprogramming ovarian follicular
development (to hasten the turnover of the second-
wave dominant follicle), thereby reducing blood estra-
diol concentrations during the periluteolysis period, as
probably achieved by hCG injections during the present
experiment. Another possibility is to use anti-inflam-
matory agents, e.g., FM, to block PGF2 synthesis, as
ttempted in the present study. To that end, further
tudies are necessary to optimize timing and doses of
uch compounds, in an attempt to increase pregnancy
ates.
In conclusion, hCG, regardless of cotreatments, ap-
arently rescued embryos from early death, as preg-
ancy rate improved 7.6%. We speculate that such
ffects were due primarily to the ability of hCG to
eprogram follicle growth to delay the onset of luteoly-
is and, ultimately, enhance embryo survival.
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